USD25.60
Size:10ml Cohen deemed MOTS -c promising enough that he founded a company to take it into a Phase I clinical trial—an early step on the road toward F.D.A EWLC lvl up bpc 157 BPC-157 — Provider-Supervised Peptide Therapy NMN Injection vs NAD research-metabolic Quantity:500 Pack – https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs44337-025-00479-3/MediaObjects/44337_2025_479_Fig1_HTML.png
USD25.60
USD27.38
USD22.70
USD23.44